These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of the effects of class 1 and class 2 heparin-binding growth factors on protein synthesis and actin mRNA expression in BALB/c-3T3 cells. Rybak SM; Lobb RR; Fett JW J Cell Physiol; 1988 Aug; 136(2):312-8. PubMed ID: 2457594 [TBL] [Abstract][Full Text] [Related]
6. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. Burgess WH; Shaheen AM; Ravera M; Jaye M; Donohue PJ; Winkles JA J Cell Biol; 1990 Nov; 111(5 Pt 1):2129-38. PubMed ID: 1699952 [TBL] [Abstract][Full Text] [Related]
9. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Winkles JA; Friesel R; Burgess WH; Howk R; Mehlman T; Weinstein R; Maciag T Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7124-8. PubMed ID: 2444975 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat. Rosengart TK; Kuperschmid JP; Maciag T; Clark RE Circ Res; 1989 Feb; 64(2):227-34. PubMed ID: 2463884 [TBL] [Abstract][Full Text] [Related]
11. Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro. Rosengart TK; Johnson WV; Friesel R; Clark R; Maciag T Biochem Biophys Res Commun; 1988 Apr; 152(1):432-40. PubMed ID: 2451918 [TBL] [Abstract][Full Text] [Related]
12. FGFs and their receptors, in vitro and in vivo studies: new FGF receptor in the brain, FGF-1 in muscle, and the use of functional analogues of low-affinity heparin-binding growth factor receptors in tissue repair. Soulet L; Chevet E; Lemaitre G; Blanquaert F; Meddahi A; Barritault D Mol Reprod Dev; 1994 Sep; 39(1):49-54; discussion 54-5. PubMed ID: 7528027 [TBL] [Abstract][Full Text] [Related]
13. Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo. Savorè C; Zhang C; Muir C; Liu R; Wyrwa J; Shu J; Zhau HE; Chung LW; Carson DD; Farach-Carson MC Clin Exp Metastasis; 2005; 22(5):377-90. PubMed ID: 16283481 [TBL] [Abstract][Full Text] [Related]